// App-Quantinova.ai

: Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study

Researchers

Presenter

  • Divya Mohan

Principal Investigators

  • Matthew Allinder

  • Julia Forman

  • Carmel Mceniery

  • Charlotte Bolton

  • John Cockcroft

  • William Macnee

  • Jonathan Fuld

  • Nichola Gale

  • Marie Fisk

  • Joseph Cheriyan

  • David Lomas

  • Peter Calverley

  • Bruce Miller

  • Ian Wilkinson

  • Ruth Tal-Singer

  • Michael Polkey

Medical Centers

  • GSK, King of Prussia, PA, United States of America

  • University of Cambridge, Division of Experimental Medicine and Immunotherapeutics & Cambridge Clinical Trials Unit, Addenbrooke’s Hospital, Cambridge, United Kingdom

  • Nottingham Respiratory Research Unit, University of Nottingham, School of Medicine, City Hospital NUH Trust Campus, Nottingham, United Kingdom

  • Department of Cardiology, Wales Heart Research Institute, Cardiff University, Cardiff, United Kingdom

  • Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  • Division of Medicine, University College London, London, United Kingdom

  • MRC/ARUK Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom

  • NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust, Middlesex, United Kingdom,

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GSK

Result

  • N/A